サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631156

インプラント周囲炎の市場規模、シェア、動向分析レポート：方法タイプ別、地域別、セグメント予測、2025年～2030年

Peri-implantitis Market Size, Share & Trends Analysis Report By Method Type (Surgical (Bone Regeneration, Open Flap Debridement, Implantoplasty), Non-surgical (Laser Debridement)), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
インプラント周囲炎の市場規模、シェア、動向分析レポート：方法タイプ別、地域別、セグメント予測、2025年～2030年
出版日: 2024年12月12日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インプラント周囲炎市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のインプラント周囲炎市場規模は、2025～2030年にかけてCAGR 9.1％で拡大し、2030年には17億5,000万米ドルに達すると予測されています。

インプラント周囲炎は、オッセオインテグレートされたインプラント周囲の軟組織と硬組織に影響を及ぼす部位特異的な破壊性炎症性疾患で、骨量の減少とインプラント周囲ポケットの形成を引き起こします。歯科インプラントの成功率は、10年間で92％～98％と報告されています。しかし、歯周炎の既往歴のある患者の増加、インプラント周囲炎の効率的な治療に関連する技術的進歩の出現、喫煙や糖尿病の傾向がある患者の増加などの要因が、市場の成長に拍車をかけています。

インプラント周囲合併症の有病率は、世界中で埋入されるインプラントの増加に伴い、増加傾向にあると予想されます。NCBIによると、米国では1999～2017年、年間14.0％のインプラント有病率の増加が記録されています。英国では年間約260,000本のインプラントが埋入されており、これは歯科インプラントの需要が高まっていることを示しています。インプラントが一般的な治療になるにつれ、インプラント周囲粘膜炎やインプラント周囲炎を含む関連疾患の有病率は正の相関を示しています。さらに、CDCによると、米国では2019年に30歳の成人の47.2％が何らかの歯周病に罹患しています。この症状は、女性よりも男性の方が喫煙や糖尿病などの健康状態になりやすいため、男性に多く見られます。レーザーデブライドメント、ガイド下骨再生（GBR）、診断用遺伝子バイオマーカー技術などの進歩が、インプラント周囲炎治療市場の成長を後押しすると期待されています。

インプラント周囲炎市場レポートハイライト

  • 外科的なデブライドメント処置は効率的であり、インプラント周囲炎を治療する最も効果的な技術であると考えられているため、2024年には外科的なセグメントが市場を独占しました。
  • レーザーデブライドメントの非外科的手法は、選択的な結石除去により臨床結果が改善し、効率的であるため、予測期間中に最も高い成長が見込まれます。
  • 2024年には、インプラント周囲炎治療の技術的進歩の高まりにより、欧州が市場を席巻します。
  • アジア太平洋では、高齢者の増加、インプラントと関連疾患に対する意識の高まり、急速な技術進歩により、予測期間中に最も高いCAGRを記録することが予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 インプラント周囲炎市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 インプラント周囲炎市場：方法タイプ別、ビジネス分析

  • 方法タイプの市場シェア、2024年と2030年
  • 方法タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、方法タイプ別、2018～2030年
  • 外科的
  • 非外科的

第5章 インプラント周囲炎市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Pfizer Inc.
    • Cadila Pharmaceuticals
    • GaronitPharma
    • Basic Pharma Life Science Pvt Ltd.
    • Prachi Pharmaceuticals Private Limited.
    • Geistlich Pharma India Pvt. Ltd.
    • Healthy Life Pharma Private Limited.
    • Zimmer Biomet.
    • Institut Straumann AG
    • Dentsply Sirona
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global peri-implantitis market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 5 North America peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 6 North America peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 7 U.S. peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 8 Canada peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 9 Mexico peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 10 Europe peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 11 Europe peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 12 UK peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 13 Germany peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 14 France peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 15 Italy peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 16 Spain peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 17 Norway peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 18 Denmark peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 19 Sweden peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 20 Asia Pacific peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 21 Asia Pacific peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 22 Japan peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 23 China peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 24 India peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 25 Australia peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 26 South Korea peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 27 Thailand peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 28 Latin America peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 29 Latin America peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 30 Brazil peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 31 Argentina peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 32 Middle East & Africa peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 33 Middle East & Africa peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 34 South Africa peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 35 Saudi Arabia peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 36 UAE peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 37 Kuwait peri-implantitis market, by method type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Peri-implantitis market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Method type outlook (USD Billion)
  • Fig. 10 Transportation mode outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Peri-implantitis market dynamics
  • Fig. 13 Peri-implantitis market: Porter's five forces analysis
  • Fig. 14 Peri-implantitis market: PESTLE analysis
  • Fig. 15 Peri-implantitis market: Method type segment dashboard
  • Fig. 16 Peri-implantitis market: Method type market share analysis, 2024 & 2030
  • Fig. 17 Surgical market, 2018 - 2030 (USD Billion)
  • Fig. 18 Bone regeneration market, 2018 - 2030 (USD Billion)
  • Fig. 19 Open flap debridement market, 2018 - 2030 (USD Billion)
  • Fig. 20 Implantoplasty market, 2018 - 2030 (USD Billion)
  • Fig. 21 Non-surgical market, 2018 - 2030 (USD Billion)
  • Fig. 22 Mechanical debridement market, 2018 - 2030 (USD Billion)
  • Fig. 23 Laser debridement market, 2018 - 2030 (USD Billion)
  • Fig. 24 Antibiotics market, 2018 - 2030 (USD Billion)
  • Fig. 25 Others market, 2018 - 2030 (USD Billion)
  • Fig. 26 Peri-implantitis market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 35 Europe peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 40 France country dynamics
  • Fig. 41 France peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 52 Asia Pacific peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 55 China country dynamics
  • Fig. 56 China peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 57 India country dynamics
  • Fig. 58 India peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 65 Latin America peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 70 MEA peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework
目次
Product Code: GVR-4-68039-099-7

Peri-implantitis Market Growth & Trends:

The global peri-implantitis market size is expected to reach USD 1.75 billion by 2030, expanding at a CAGR of 9.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%-98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.

The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.

Peri-implantitis Market Report Highlights:

  • The surgical segment dominated the market in 2024 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis
  • Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal
  • Europe dominated the market in 2024 owing to the rising technological advancements for peri-implantitis treatment
  • In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Method Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Peri-implantitis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Peri-implantitis Market: Method Type Business Analysis

  • 4.1. Method Type Market Share, 2024 & 2030
  • 4.2. Method Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Method Type, 2018 to 2030 (USD Billion)
  • 4.4. Surgical
    • 4.4.1. Surgical Market, 2018 - 2030 (USD Billion)
    • 4.4.2. Bone Regeneration
      • 4.4.2.1. Bone Regeneration Market, 2018 - 2030 (USD Billion)
    • 4.4.3. Open Flap Debridement
      • 4.4.3.1. Open Flap Debridement Market, 2018 - 2030 (USD Billion)
    • 4.4.4. Implantoplasty
      • 4.4.4.1. Implantoplasty Market, 2018 - 2030 (USD Billion)
  • 4.5. Non-surgical
    • 4.5.1. Non-surgical Market, 2018 - 2030 (USD Billion)
    • 4.5.2. Mechanical Debridement
      • 4.5.2.1. Mechanical Debridement Market, 2018 - 2030 (USD Billion)
    • 4.5.3. Laser Debridement
      • 4.5.3.1. Laser Debridement Market, 2018 - 2030 (USD Billion)
    • 4.5.4. Antibiotics
      • 4.5.4.1. Antibiotics Market, 2018 - 2030 (USD Billion)
    • 4.5.5. Others
      • 4.5.5.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Peri-implantitis Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework
      • 5.4.2.3. Competitive Insights
      • 5.4.2.4. U.S. Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework
      • 5.4.3.3. Competitive Insights
      • 5.4.3.4. Canada Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Regulatory Framework
      • 5.4.4.3. Competitive Insights
      • 5.4.4.4. Mexico Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Europe
    • 5.5.1. Europe Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. UK Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Germany Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. France Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Competitive Insights
      • 5.5.5.4. Italy Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Competitive Insights
      • 5.5.6.4. Spain Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.7. Norway
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Competitive Insights
      • 5.5.7.4. Norway Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Competitive Insights
      • 5.5.8.4. Denmark Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.9. Sweden
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Competitive Insights
      • 5.5.9.4. Sweden Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. Japan Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. China Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. India Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.5. South Korea
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. South Korea Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.6. Australia
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Australia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Thailand Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Latin America
    • 5.7.1. Latin America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. Brazil Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Argentina Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. MEA
    • 5.8.1. MEA Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. South Africa Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Saudi Arabia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Competitive Insights
      • 5.8.4.4. UAE Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Competitive Insights
      • 5.8.5.4. Kuwait Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Pfizer Inc.
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Method Type Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. Cadila Pharmaceuticals
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Method Type Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. GaronitPharma
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Method Type Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Basic Pharma Life Science Pvt Ltd.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Method Type Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. Prachi Pharmaceuticals Private Limited.
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Method Type Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. Geistlich Pharma India Pvt. Ltd.
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Method Type Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. Healthy Life Pharma Private Limited.
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Method Type Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. Zimmer Biomet.
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Method Type Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. Institut Straumann AG
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Method Type Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. Dentsply Sirona
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Method Type Benchmarking
      • 6.5.10.4. Strategic Initiatives